Inventor · disambiguated record

Hervé Guillard

Also filed as: GUILLARD HERVE · GUILLARD HERVÉ

38 granted patents·12 pending applications·706 citations·filing 2001–2025

98Inventor score

Technology areasA61K A61P A61J C09K

Files withFLAMEL IRELAND LTD48 POLYMAGE SARL1 WETTERAU JOHN R1

Top patents by PatentIndex Score

50 records

0199US11839597B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Dec 12, 2023·27 cites·30 claims
0299US11065224B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 20, 2021·42 cites·38 claims
0399US10973795B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Apr 13, 2021·48 cites·24 claims
0499US10952986B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Mar 23, 2021·50 cites·31 claims
0598US11052061B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 6, 2021·33 cites·24 claims
0698US11000498B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted May 11, 2021·38 cites·20 claims
0797US12128021B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Oct 29, 2024·12 cites·26 claims
0897US12097175B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·9 cites·30 claims
0997US11986451B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted May 21, 2024·24 cites·26 claims
1097US11504347B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Nov 22, 2022·38 cites·25 claims
1197US10736866B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Aug 11, 2020·53 cites·52 claims
1297US10272062B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2017·Granted Apr 30, 2019·68 cites·89 claims
1396US12257223B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 25, 2025·2 cites·14 claims
1496US12138239B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 12, 2024·9 cites·30 claims
1596US12115145B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·29 claims
1696US12115144B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·15 claims
1796US12115143B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·26 claims
1896US12115142B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·30 claims
1996US11896572B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Feb 13, 2024·28 cites·1 claims
2096US11826335B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 28, 2023·27 cites·10 claims
2196US11766418B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Sep 26, 2023·27 cites·11 claims
2296US11602512B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·11 claims
2396US11602513B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·27 claims
2496US11583510B1Methods of administering gamma hydroxybutyrate formulations after a high-fat mealFLAMEL IRELAND LTD·Filed 2022·Granted Feb 21, 2023·37 cites·14 claims
2595US12226388B2Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·2 cites·29 claims
2695US11779557B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Oct 10, 2023·7 cites·6 claims
2794US12263150B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·19 claims
2894US12263151B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·15 claims
2994US12239625B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 4, 2025·1 cites·15 claims
3094US12226389B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·1 cites·14 claims
3194US12186298B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Jan 7, 2025·1 cites·26 claims
3294US12109186B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 8, 2024·1 cites·11 claims
3393US12186296B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Jan 7, 2025·2 cites·63 claims
3489US12144793B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 19, 2024·0 cites·23 claims
3589US12097176B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·0 cites·6 claims
3689US2024366548A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
3784US2025099417A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
3880US2022016066A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Application pending·0 cites
3980US2025205187A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
4079US2021267928A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Application pending·0 cites
4178US2023210804A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Application pending·0 cites
4274US12478604B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Nov 25, 2025·0 cites·15 claims
4372US12295926B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted May 13, 2025·0 cites·7 claims
4468US2021137843A1Packaged modified release gamma-hydroxybutyrate formulations having improved stabilityFLAMEL IRELAND LTD·Filed 2021·Application pending·0 cites
4566US2024216283A1Gamma-hydroxybutyrate formulations having improved stability after storageFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
4666US2020360293A1Packaged modified release gamma-hydroxybutyrate formulations having improved stabilityFLAMEL IRELAND LTD·Filed 2020·Application pending·0 cites
4761US2019183806A1Packaged modified release gamma-hydroxybutyrate formulations having improved stabilityFLAMEL IRELAND LTD·Filed 2018·Application pending·0 cites
4850US2010015220A1Niacin and nsaid combination therapyWETTERAU JOHN R·Filed 2009·Application pending·0 cites
4946US7270769B2Precursor for preparing an optical material, method and optical components obtained with same and uses thereofPOLYMAGE SARL·Filed 2001·Granted Sep 18, 2007·5 cites·17 claims
5043US2025152546A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Hervé Guillard files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →